Samvat to Samvat: Nifty ends lower, while pharma and metals shine
A challenging Samvat for Indian equities still offered pockets of strong gains, with pharma and metal stocks leading the way while several heavyweight stocks faced sharp declines.

A challenging Samvat for Indian equities still offered pockets of strong gains, with pharma and metal stocks leading the way while several heavyweight stocks faced sharp declines.

Headline, summary and picture belong to CNBC-TV18, from its public news feed. We don’t copy the article; the full text is on CNBC-TV18’s site. Prices: Yahoo Finance, delayed.



